Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Comparison of Ertty Gap III and Facemask Therapy for Skeletal Class III Correction

NCT: NCT07771660 · COMPLETED

NCT IDNCT07771660
StatusCOMPLETED
Start Date2024-05-25
Completion2025-12-09
SponsorAnkara University (OTHER)
First posted
Last updated

Brief Summary

This single-center, parallel-group randomized clinical trial compared 2 orthopedic treatment approaches in growing patients with skeletal Class III malocclusion associated predominantly with maxillary deficiency: the Ertty Gap III appliance and facemask therapy. Forty-two participants were randomly allocated in a 1:1 ratio to Ertty Gap III or facemask therapy. The primary objective was to compare the short-term skeletal effects of the 2 treatment protocols, with the ANB angle designated as the primary outcome. Skeletal, dentoalveolar, and soft-tissue outcomes were assessed using standardized lateral cephalometric radiographs obtained before treatment and at treatment completion.

Frequently Asked Questions

What is Comparison of Ertty Gap III and Facemask Therapy for Skeletal Class III Correction?

Comparison of Ertty Gap III and Facemask Therapy for Skeletal Class III Correction is a clinical trial registered under NCT07771660. Current status: COMPLETED.

What is the status of NCT07771660?

The current status of NCT07771660 (Comparison of Ertty Gap III and Facemask Therapy for Skeletal Class III Correction) is: COMPLETED.

When did Comparison of Ertty Gap III and Facemask Therapy for Skeletal Class III Correction start?

Comparison of Ertty Gap III and Facemask Therapy for Skeletal Class III Correction started on 2024-05-25.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑